Fees

Axon Raises Curtain on Second ACT

Axon's new ACT tool will provide speedier and more accessible data on a firm's application data usage, as well as—when used with its PEAR tool—helping to understand the cost impact of exchange policy changes.

Firms Drag Heels on MiFID II Research Rulebook Rewrite

MiFID II’s ban on broker-subsidized free research will leave sell-side firms with a multitude of challenges—not least how to price research so as not to lose customers who might direct trading elsewhere, without appearing to incentivize clients to trade…

You must be signed in to use this feature.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: